Samsung has received U.S. Food and Drug Administration (FDA) 510(k) clearance for version 3.02 of its S-Vue digital radiography (DR) image postprocessing engine, which is designed to significantly lower radiation dose for pediatric patients.
After comparing S-Vue 3.02 with the firm's previous postprocessing engine on phantoms and in clinical studies, Samsung said that DR systems using S-Vue were able to lower dose by up to 45% for pediatric abdomen exams, by 15.5% for pediatric chest studies, and by up to 27% for pediatric skull exams.
S-Vue 3.02 is available on Samsung's GC85A and GM85 DR systems.
![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
